Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Tom Kouroukis"'
Autor:
Leslie Verville, Cassandra McKay, Tom Kouroukis, Suzanna Apostolovski, Mitchell Sabloff, Rena Buckstein, Kardi Kennedy, Karen Yee, Amanda Eakins, Christopher Bredeson
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4656-4674 (2024)
Acute leukemia is a rapidly progressive cancer of the blood and bone marrow that requires a high degree of complex, specialized, resource-intensive clinical and supportive care. The aging Canadian population has introduced an unprecedented demand on
Externí odkaz:
https://doaj.org/article/abcb2b5853a245e590c9b9d36eaa28ce
Autor:
Alissa Visram, Kelvin Kar-Wing Chan, Hsien Seow, Gregory Pond, Anastasia Gayowsky, Ghulam Rehman Mohyuddin, Arleigh McCurdy, Irwindeep Sandhu, Christopher Venner, Guido Lancman, Amaris Balitsky, Tom Kouroukis, Robert Bruins, Shaji Kumar, Rafael Fonseca, Hira Mian
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/a58990cd39774fcc882a1c883456b5f0
Autor:
Amaris Balitsky, Greg Pond, Gwynivere Davies, Graeme Fraser, Tom Kouroukis, Mark Levine, Ralph Meyer, Ronan Foley
Purpose Chimeric antigen receptor T-cell (CART) therapy has shown clinical efficacy in refractory and relapsed large B-cell lymphomas, but is associated with serious acute and long-term toxicities. To understand the patient perspective, we measured a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80454d07473cf8cc05e7cf73b01e0a51
https://doi.org/10.21203/rs.3.rs-2907146/v1
https://doi.org/10.21203/rs.3.rs-2907146/v1
Publikováno v:
Blood. 140:8036-8037
Autor:
Christopher Bredeson, Graeme Fraser, Michael Crump, Andrew Aw, Matthew C. Cheung, S. Bhella, Norma P. Varela, S. Sajkowski, Tom Kouroukis
Publikováno v:
Curr Oncol
Current Oncology
Volume 27
Issue 6
Pages 7053-644
Current Oncology
Volume 27
Issue 6
Pages 7053-644
Background: In Ontario, no clearly defined standard of care for the management of mantle cell lymphoma (mcl) has been developed, and substantial variability from centre to centre is evident. This guidance document was prompted by the need to harmoniz
Autor:
Sarah E. Ferguson, Rebecca E Mercer, C. Tom Kouroukis, Gail Darling, Maureen E. Trudeau, Wei Fang Dai, Scott Gavura, James Keech, Rohini Naipaul, Frances C. Wright, Kelvin K. W. Chan, Andrea Eisen, Jaclyn Beca
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:404-409
ObjectivesThe pan-Canadian Oncology Drug Review (pCODR) evaluates new cancer drugs for public funding recommendations. While pCODR's deliberative framework evaluates overall clinical benefit and includes considerations for exceptional circumstances,
Autor:
Hsien Seow, C. Tom Kouroukis, Hira S. Mian, Jonathan Sussman, Branavan Sivapathasundaram, Tanya M. Wildes, Gregory R. Pond
Publikováno v:
Journal of geriatric oncology. 12(4)
Multiple myeloma, a cancer of older adults, has seen significant improvement in therapeutic options over the past two decades. Uncovering disparities in treatment patterns and outcomes is imperative in order to ensure older adults, who are underrepre
Publikováno v:
Leukemialymphoma. 61(5)
The International Extranodal Lymphoma Study Group-32 (IELSG32) randomized patients with primary central nervous system lymphoma (PCNSL) for induction treatment with methotrexate-cytarabine, methotrexate-cytarabine-rituximab, or methotrexate-cytarabin
Autor:
Karen W.L. Yee, Mary Catherine McCann, Cassandra McKay, Amanda Wong, Sherrie Hertz, C. Tom Kouroukis, Rena Buckstein, Kardi Kennedy, Christopher Bredeson, Lia I. T. Kutzscher, Mitchell Sabloff, Janet MacEachern, Suzanna Apostolovski
Publikováno v:
Blood. 138:3013-3013
Introduction: In Ontario, Canada, acute leukemia (AL) care is delivered to patients at three levels of specialized service provider sites: 1) Transplant and AL Service Sites, providing all services, including stem cell transplant, chimeric antigen re
Autor:
Joshua Xu, Dina Khalaf, Kylie Lepic, Hassan Zahreddine, Tobias Berg, Tom Kouroukis, Justin Lee, Irwin Walker, Brian Leber, Parveen Wasi, Tony Chen, Christopher M. Hillis
Publikováno v:
Blood. 138:3379-3379
Background: AML is a complex disease that encompasses a huge variation of cytogenetic and mutational backgrounds, which is often complicated by age related functional deficits (Klepin et al. 2013). Given the expanding availability of reduced-intensit